GlaxoSmithKline PLC said Monday that clinical data shows its cervical cancer vaccine candidate Cervarix is effective for more than six years against a virus that can cause cervical cancer.

Read more: http://money.cnn.com/news/newsfeeds/articles/apwire/3c20ddbe78af687fa29d6db5e91d4eda.htm